Total Payments
$2,735
2024 Payments
$1,460
Companies
27
Transactions
131
Medicare Patients
189,022
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$2,695 (98.5%)
Consulting$20.00 (0.7%)
Education$19.84 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,695 | 129 | 98.5% |
| Consulting Fee | $20.00 | 1 | 0.7% |
| Education | $19.84 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $733.53 | 29 | $0 (2024) |
| ABBVIE INC. | $345.53 | 18 | $0 (2024) |
| Amgen Inc. | $246.60 | 12 | $0 (2024) |
| PFIZER INC. | $191.50 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $177.08 | 10 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $149.91 | 8 | $0 (2024) |
| Lilly USA, LLC | $123.49 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $112.47 | 5 | $0 (2024) |
| Exact Sciences Corporation | $94.56 | 5 | $0 (2024) |
| Abbott Laboratories | $74.04 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,460 | 62 | Novo Nordisk Inc ($391.56) |
| 2023 | $860.49 | 44 | Novo Nordisk Inc ($171.04) |
| 2022 | $19.78 | 1 | Abbott Laboratories ($19.78) |
| 2021 | $14.83 | 1 | Amarin Pharma Inc. ($14.83) |
| 2020 | $50.49 | 3 | Novartis Pharmaceuticals Corporation ($17.75) |
| 2019 | $95.92 | 5 | Genentech USA, Inc. ($23.17) |
| 2018 | $125.07 | 8 | Novo Nordisk Inc ($81.56) |
| 2017 | $108.19 | 7 | Novo Nordisk Inc ($58.35) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Biological | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Respiratory | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: PAIN | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: VACCINES | ||||||
| 09/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Obesity | ||||||
| 07/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 52,442 | 74,453 | $5.4M | $983,057 |
| 2022 | 56 | 50,607 | 72,759 | $5.0M | $838,122 |
| 2021 | 51 | 45,485 | 64,667 | $4.5M | $782,555 |
| 2020 | 39 | 40,488 | 56,864 | $4.0M | $664,780 |
Total Patients
189,022
Total Services
268,743
Medicare Billing
$3.3M
Procedure Codes
203
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 7,458 | 12,470 | $1.2M | $128,884 | 10.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 6,031 | 8,454 | $845,400 | $110,745 | 13.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 4,383 | 5,785 | $526,435 | $95,180 | 18.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 6,333 | 10,093 | $242,232 | $84,623 | 34.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 6,458 | 9,578 | $363,964 | $72,822 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 719 | $148,835 | $64,655 | 43.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 1,660 | 1,908 | $225,144 | $55,299 | 24.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 3,855 | 5,785 | $266,110 | $54,992 | 20.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 1,568 | 1,825 | $208,050 | $32,871 | 15.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 108 | 108 | $58,860 | $30,528 | 51.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 2,350 | 3,098 | $235,448 | $27,329 | 11.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 185 | 185 | $55,500 | $23,473 | 42.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 1,357 | 1,589 | $144,599 | $23,432 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 321 | $48,615 | $19,615 | 40.3% |
| 82747 | Folic acid level, rbc | Office | 2023 | 941 | 1,060 | $89,040 | $18,306 | 20.6% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 758 | 945 | $85,995 | $15,624 | 18.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 662 | 891 | $62,354 | $11,892 | 19.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 537 | 537 | $31,202 | $10,142 | 32.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 844 | 1,069 | $31,001 | $8,827 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 61 | $21,960 | $7,641 | 34.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 98 | 98 | $13,230 | $7,049 | 53.3% |
| 83550 | Iron binding capacity | Office | 2023 | 568 | 782 | $35,972 | $6,694 | 18.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 52 | 52 | $18,980 | $6,681 | 35.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 1,730 | 2,057 | $78,166 | $6,382 | 8.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 741 | 993 | $78,447 | $5,610 | 7.2% |
About Dr. Richard Kim, MD
Dr. Richard Kim, MD is a Internal Medicine healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902890981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Kim, MD has received a total of $2,735 in payments from pharmaceutical and medical device companies, with $1,460 received in 2024. These payments were reported across 131 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,695).
As a Medicare-enrolled provider, Kim has provided services to 189,022 Medicare beneficiaries, totaling 268,743 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Leesburg, VA
- Active Since 09/07/2005
- Last Updated 11/29/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902890981
Products in Payments
- Wegovy (Drug) $316.29
- VRAYLAR (Drug) $264.15
- Ozempic (Drug) $203.42
- Otezla (Drug) $169.57
- REXULTI (Drug) $112.47
- MOUNJARO (Drug) $109.38
- FARXIGA (Drug) $100.08
- Cologuard Collection Kit (Device) $94.56
- Rybelsus (Drug) $92.82
- Qelbree (Drug) $74.07
- NURTEC ODT (Drug) $73.02
- Veozah (Drug) $68.39
- Victoza (Drug) $64.44
- BREZTRI (Drug) $62.55
- PAXLOVID (Drug) $56.64
- QELBREE (Drug) $53.58
- EVENITY (Biological) $50.76
- GARDASIL (Biological) $45.78
- SYNTHROID (Drug) $45.08
- TRADJENTA (Drug) $42.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Leesburg
Dr. David Lichtinger, D.o, D.O
Internal Medicine — Payments: $17,918
Internal Medicine $17,918
Jahanbakhsh Naghshin, M.d, M.D
Internal Medicine — Payments: $13,133
Internal Medicine $13,133
Sheyla Zelaya-Aragon
Internal Medicine — Payments: $11,938
Internal Medicine $11,938
Diane Traficante, Do, DO
Internal Medicine — Payments: $9,193
Internal Medicine $9,193
Dr. Ravi Gupta, M.d, M.D
Internal Medicine — Payments: $8,000
Internal Medicine $8,000
Dr. Sepehr Mesdaghinia, M.d, M.D
Internal Medicine — Payments: $6,588
Internal Medicine $6,588